Michael Benkowitz, PRESIDENT AND COO at UNITED THERAPEUTICS Corp (UTHR), sold 59,625 shares at $502.79 ($24.3M) on 2025-12-29, disclosed to the SEC on 2025-12-30.
Scheduled sale ($24.3M) by PRESIDENT AND COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $117.76 | 14,625 | $1.7M | 7.1% |
| 2 | $502.79 | 7,875 | $4.0M | 16.3% |
| 3 | $502.79 | 7,875 | $4.0M | 16.3% |
| 4 | $502.79 | 14,625 | $7.4M | 30.2% |
| 5 | $502.79 | 14,625 | $7.4M | 30.2% |
| Total | $408.35 avg | 59,625 |
| $24.3M |
| 100% |
| Filing → |
| UTHR | SELL | 2026-02-10 | $21.4M | — | Filing → |
| UTHR | SELL | 2026-02-03 | $21.2M | — | Filing → |
| UTHR | SELL | 2026-01-28 | $13.5M | — | Filing → |